Surgical Science Sweden AB (publ) (STO: SUS)

Market Cap	6.33B
Revenue (ttm)	838.25M
Net Income (ttm)	197.72M
Shares Out	51.03M
EPS (ttm)	3.87
PE Ratio	32.00
Forward PE	28.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	174,773
Open	127.60
Previous Close	127.60
Day's Range	124.00 - 128.10
52-Week Range	115.10 - 196.90
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 265
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SUS

Financial Performance

In 2023, SUS's revenue was 882.85 million, an increase of 10.01% compared to the previous year's 802.54 million. Earnings were 233.97 million, an increase of 24.47%.